Abstract: Porphyrins and porphyrin derivatives have been widely explored for various applications owing to their excellent photophysical and electrochemical properties. However, inherent shortcomings, such as the instability and self-quenching in physiological conditions, limit their biomedical applications. In recent years, metal-organic frameworks (MOFs), as a new type of hybrid porous coordination polymers assembled from metal ions/secondary building units (SBUs) and organic linkers, have gained increasing attention. The construction of porphyrin-based MOFs by introducing porphyrin molecules into MOFs or using porphyrins as organic linkers to form MOFs can integrate the unique features of porphyrins and MOFs as well as overcome the limitations of porphyrins, facilitating their biomedical applications. This review article summarizes important synthesis strategies for porphyrin-based MOFs including porphyrin@MOFs, porphyrinic MOFs and composite porphyrinic MOFs, and highlights recent achievements and progress in the field of porphyrin-based MOFs for biomedical applications in tumor therapy and biosensing. Finally, the challenges and prospects of this class of emerging materials for biomedical applications are discussed. Figure 1. Prominent applications of porphyrins and porphyrin derivatives.
Introduction
Porphyrins are macromolecular heterocyclic compounds composed of porphin (C20H14N4) substituted by various functional groups at the meso-position or β-position. [1] In addition, free-base porphyrins can be coordinated with numerous metal ions in the porphyrin center to form metal complexes, also known as metalloporphyrins. [2] In fact, many porphyrins and metalized porphyrin derivatives exist in nature and organisms and play significant roles, such as cytochrome, heme and chlorophyll. The porphyrin family discovered up to now as functional molecules have been comprehensively studied. [3] Due to their large πaromatic system, porphyrins possess excellent chemical and thermal stabilities as well as distinct photophysical and electrochemical performances, which can be regulated by the substitution patterns on porphin and the coordinated metal ions. Except for the central metallization, the periphery site of porphyrins can also be bound to metal ions to form peripherally metalized porphyrins. [4] Intricate binding modes enable porphyrins to form desirable molecular cages or framework solids. [5] Porphyrins and porphyrin derivatives are an important class of organic chromophores, with the considerable absorption in the visible section of the electromagnetic spectrum. Normally, the absorption spectrum shows the strongest absorption around 400~450 nm (Soret band), and a series of gradually reduced absorption bands between 500 and 700 nm (Q-bands). [1] To date, porphyrins and porphyrin derivatives have been applied for various applications due to their characteristics and versatile functions (Figure 1) . For instance, the pronounced visible light absorption and energy migration allow porphyrins to be used in light-harvesting, solar cells and molecular electronics. [6] The chemical catalytic activity of porphyrins, especially metalloporphyrins, render them as efficient photocatalysts, electrocatalysts and biomimetic catalysts. [7] The regulation of optical and electronic properties caused by the coordination of metal ions and the axial coordination of molecules, enable their application in molecular recognition and metal ions sensing. [8] More importantly, porphyrins exist in many biological processes and produce essential effects. Therefore, they possess potent biological performances, such as biocompatibility, effective clearance, longer residence time in tumors, less side effect and mimicking of various biological functions, which are extremely useful for biomedical applications. [9] For example, porphyrins have been widely developed as photosensitizers for photodynamic therapy (PDT). At the same time, their fluorescence characteristics, render porphyrin-based photosensitizers as valuable fluorescence imaging-guided therapy systems. [9b] However, the drawbacks of most of porphyrins and porphyrin derivatives, in particular instability, enzymatic degradation, nonspecific targeting, and propensity to REVIEW To date, a variety of strategies have been proposed to synthesize NMOFs and have been summarized in several reviews. [23] Particularly for the synthesis of NMOFs, several efficient methods have also been developed, including hydrothermal/solvothermal, sonochemical, mechanochemical, microwave-assisted synthesis and reverse microemulsion. However, there are no reports on highlighting the synthesis of porphyrin-based MOFs yet.
Typically, porphyrin-based MOFs can be divided into porphyrin@MOFs and porphyrinic MOFs according to the distinct structures assembled from porphyrins and MOFs. For porphyrin@MOFs, free-base porphyrins or metalloporphyrins as guest molecules are integrated into MOFs via the encapsulation in the pores as well as adsorption or grafting on the surface. While as organic linkers, free-base porphyrins/metalloporphyrins could coordinate with metal ions or SBUs to form porphyrinic/metalloporphyrinic MOFs. On the other hand, porphyrinic/metalloporphyrinic MOFs can be combined with other functional components, like magnetic nanoparticles, photothermal agents and fluorescent quantum dots, to form multifunctional platforms. Actually, the morphology, structure and composition of porphyrin-based MOFs are vital for biomedical applications, and much effort has been devoted to synthesize porphyrin-based MOFs for matching the requirements in biomedical applications.
Synthesis of porphyrin@MOFs
To synthesize porphyrin@MOFs, free-base porphyrins or metalloporphyrins are typically encapsulated into the pores or decorated on the surface of MOFs, and in situ formation and postsynthesis methods are mainly used for the porphyrin-integrating processes (Figure 2 ). [19] As shown in the scheme, the in situ formation method refers to a one-pot reaction of MOF precursors (i.e., metal nodes and organic linkers) with free-base porphyrins/metalloporphyrins. During the formation of frameworks, free-base porphyrins/metalloporphyrins are simultaneously entrapped inside MOFs like ''ship-in-a-bottle". In contrast, postsynthesis methods realize the encapsulation into pores or grafting on the surface of MOFs through host-guest reactions between synthetic MOFs and free-base porphyrins/metalloporphyrins, such as hydrogen bonding, van der Waals forces, electrostatic interactions, π-π stacking interactions, covalent bonds or even coordinative bonds. [24] To date, a variety of porphyrin@MOFs have been successfully synthesized, and some typical examples are summarized in Table 1 .
Using in situ formation method to encapsulate porphyrins in the interior of MOFs, small pore windows could prevent the leakage of porphyrins as well as facilitate the diffusion of smaller molecules. Eddaoudi et al. for the first time successfully decorated MOFs with porphyrins by in situ formation in 2008. [25] The encapsulation of cationic 5,10,15,20-tetrakis(1-methyl-4pyridinio)porphyrin (TMPyP) in rho-ZMOF (indium-imidazoledicarboxylate-based zeolite-like metal-organic framework) was achieved via one-pot reaction of In 3+ , 4,5-imidazoledicarboxylic acid (H3ImDC) and TMPyP in an N,N ′ -dimethylformamide (DMF)/acetonitrile (CH3CN) solution. Furthermore, Mn, Co, Cu and Zn ions could be used for the metalation of the encapsulated free-base porphyrins.
Due to the simplified synthesis and high efficiency of porphyrin encapsulation by in situ formation method, many groups have attempted to synthesize porphyrin@MOFs as functional platforms for biomedical applications. Among them, the porphyrin@UiO-66 and porphyrin@MIL-88(Fe) have been successfully synthesized, which not only protected the free-base porphyrins or metalloporphyrins by encapuslation, but also consisted of biocompatible Zr and Fe ions. [26] For example, Dong et al. reported the synthesis of UiO-66 for encapsulating the synthetic 5,15-di(4-carboxyphenyl)-10,20-bis(4iodophenyl)porphyrin zinc(II) (DTPP(Zn)-I2) by in situ formation method, [26a] and the loading capacity of DTPP(Zn)-I2 in UiO-66 was estimated to be ca. 1.4 wt%, which was much higher compared to normal impregnating method (0.06 wt %).
For post-synthesis functionalization, the construction of porphyrin@MOFs generally requires appropriate interactions between porphyrins and MOFs, and the following issues require consideration: (i) MOFs should be activated to eliminate solvent molecules in pores or channels before decoration; (ii) the size and shape of porphyrins should match with the MOFs' pores or channels, which allows the entrance of porphyrins throughout the integration process; (iii) bond formation should be triggered between porphyrin and the framework. For example, Demel et al. developed a phosphinate-based MOF, (ICR-2, Inorganic Chemistry Rez No. 2), which could be decorated with anionic 5,10,15,20-tetrakis(4-R-phosphinatophenyl)porphyrins (TPPPi(R), R=methyl, isopropyl, phenyl) by the interaction with the unsaturated metal sites on ICR-2 surface. [27] A higher fraction of TPPPi(R) could be decorated on MOFs compared with the commercially available 5,10,15,20-tetrakis(4carboxyphenyl)porphyrin (TCPP), which might be attributed to the stronger bond of phosphinic groups in TPPPi(R) to metal ions than carboxylic groups in TCPP. REVIEW assembled by 5,10,15,20-tetrakis(4-pyridyl)porphyrin palladium(II) (TPyP(Pd)) as linkers and Cd 2+ ions as nodes. Interestingly, SBUs, also termed metal clusters, could be formed through stable metal-oxygen bonds or metal-nitrogen bonds. Such units play a key role for improving structural stability, generating more coordination sites, promoting frameworks extension, avoiding structural interpenetration and expanding pores in MOFs. Therefore, SBUs as nodes can construct robust porphyrinic MOFs with high stability, and recently increasing attention has emerged due to their potential biomedical applications. [29] In 2002, Suslick et al. for the first time reported a stable porphyrinic MOF, (PIZA-1, porphyrinic Illinois zeolite analogue No. 1) by using SBUs as nodes, [30] which was synthesized via self-assembly of trinuclear Co(II)-carboxylate clusters and Co(III)-metalloporphyrin linkers through a solvothermal treatment. This porphyrinic MOFs exposed large and refillable tri-directional channels, and exhibited significant hydrophilic character.
The rational choice of porphyrins plays a vital role in regulating the pores, shapes and sizes of porphyrinic MOFs during synthesis process. [31] Among them, carboxy-based porphyrins have been widely used as linkers to synthesize porphyrinic MOFs, such as TCPP and its metalized molecules (TCPP(M)). [31a] Generally, free-base porphyrins can form porphyrinic MOFs without metal chelating, while the cores of freebase porphyrins can be pre-metalized or metalized by in situ chelation or post chelation with various metal ions to generate metalloporphyrinic MOFs. On the other hand, it is interesting that weakly coordinated metal ions can be exchanged by other affine metal ions, [32] and thereby achieve alternative approaches to synthesize stable porphyrinic MOFs.
To date, various metal nodes, such as Cu, Zn, Co and Cd ions, have been used to assemble with TCPP or TCPP(M) linkers to form 2D MOFs (Figure 3 ). [6e, 33] For example, Zhang et al. reported for the first time a surfactant-assisted method to synthesize homogeneous ultrathin 2D MOF nanosheets (Zn-TCPP) with a thickness of sub-10 nm. [33c] In 2D Zn-TCPP nanosheets, one TCPP ligand was linked by four Zn paddlewheel metal nodes (Zn2(COO)4) and the TCPP ligand was metallized by Zn ions in the course of the formation. This strategy was also used to prepare several different types of ultrathin 2D porphyrinic MOF nanosheets, including Cu-TCPP, Cd-TCPP and Co-TCPP. Recently, Hong et al. utilized TCPP(Fe) ligands to link various divalent metal ions (Zn, Co and Cu) for constructing a series of 2D metalloporphyrinic MOF nanosheets. [33e] However, the coordination of TCPP or TCPP(M) with Mn, Fe, Zr, Hf-based clusters relatively easy forms porphyrinic MOFs with typical 3D topologies (Figure 3) . [34] Zhou et al. reported several porphyrinic MOFs (porous coordination networks, PCNs) with different topologies by a solvothermal method, [35] Further, MOF-525 and MOF-545 could be post-metalized with Fe 3+ and Cu 2+ to  yield metalloporphyrinic MOFs without losing their high surface  area and chemical stability. Interestingly, many studies have proposed the coordination between metal nodes and two or more kinds of linkers to construct multivariate MOFs for introducing multiple functionalities into MOFs. [36] Here, the introduction of other organic linkers into porphyrinic MOFs can regulate the physicochemical properties of porphyrins or endow frameworks with additional functions. For instance, Zhou et al. developed a photochromic MOF (SO-PCN, singlet oxygen-generating porous coordination network), which was constructed by self-assembly of dual linkers, 1,2-bis(2methyl-5-(pyridin-4-yl)thiophen-3-yl)cyclopent-1-ene (BPDTE) and TCPP, with Zn nodes. [36a] Due to the integration of a photochromic switch BPDTE into porphyrinic MOFs, SO-PCN showed a reversible control over photosensitization of porphyrins by an energy transfer process upon irradiation at specific wavelengths, and thereby met the requirements for photo-control applications.
Nowadays, various porphyrinic MOFs with different structures have been synthesized due to the diversity of porphyrins and metal nodes. Similar to other MOFs, the crystal down-sizing of porphyrinic MOFs to the nanoscale can also be achieved to improve the physiochemical and biological properties for biomedical applications. Solvothermal synthesis is by far the most common method for synthesizing porphyrinic NMOFs. [35d, 37] Here, the types of metal nodes and porphyrins, the reaction conditions, solvent species, stoichiometry, molecular modulators, temperature and reaction time, are the key factors to control the size and morphology of porphyrinic NMOFs, which could be carefully considered in synthesis process. Table 2 summarizes typical synthesis schemes for porphyrinic MOFs in biomedical applications. 
Synthesis of composite porphyrinic MOFs
To endow porphyrinic MOFs with multifunctionality, the incorporation of functional components into porphyrinic MOFs to construct composite porphyrinic MOFs is a useful strategy. To date, various functional components (e.g., magnetic nanoparticles, upconversion nanoparticles (UCNPs), biomolecules) have been introduced to form composite porphyrinic MOFs for biomedical applications. [38] For example, Zhang et al. reported the growth of porphyrinic MOFs on the surfaces of polydopamine nanoparticles, graphene oxide sheets and gold nanorods to form core-shell composite porphyrinic MOFs. [38g] This strategy was driven by controlling the coordination interactions between functional groups of nanostructures and Zr metal nodes, which could not only avoid the self-nucleation of MOFs in solution, but also control the thickness of porphyrinic MOFs. More interestingly, Li et al. reported in situ growth of porphyrinic MOFs on the polyvinylpyrrolidone (PVP)-coated lanthanide-doped UCNPs to form UCNPs/PMOF heterodimers with asymmetric compositions. [38c] From this point of view, the surface interactions including electrostatic forces, hydrophobic interactions, covalent or coordinate bonds, are critical factors to control composite porphyrinic MOFs with well-defined morphology. Therefore, surface modifications are necessary for the fabrication of composite porphyrinic MOFs. The intricate interactions in composite porphyrinic MOFs also affect the degradation characteristics. For example, the high affinity of Zr cations to phosphate anions can result in the disassembly of Zr-based porphyrinic MOFs. Ren et al. evaluated the degradation degree of platinum-decorated PCN-224 (PCN-224-Pt) and PCN-224 in phosphate-buffered saline (PBS). [39] The results indicated that PCN-224-Pt degraded and released TCPP ligands more slowly than PCN-224 due to the strong covalent interaction between Pt and PCN-224. Moreover, surface decorating MOFs with biocompatible composition (e.g., polyethylene glycol (PEG), PVP) can improve their stability and prolong circulation time in biological environments. Despite a variety of composite porphyrinic MOFs have been synthesized, the complicated synthesis process, low yield and high wasteful production still restrict their developments in biomedical applications. 
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Biomedical applications of porphyrin-based MOFs
Porphyrin-based MOFs offer a variety of attractive features making use of the integration of porphyrins into MOFs, in particular excellent photophysical and electrochemical properties, porous structure, modular functionalization and biocompatibility. These characteristics are beneficial for the applications of porphyrin-based MOFs in biomedicine, which have attracted more and more attention. Nowadays, numerous interesting biomedical applications, such as drug delivery, tumor therapy, bioimaging and biosensing, have been developed for porphyrinbased MOFs. In the following, we summarize recent progress in the area of biomedical applications of porphyrin-based MOFs, including photodynamic therapy (PDT), synergistic therapy, imaging-guided therapy and biosensing (Figure 4 ).
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cells. [40] As a result, PDT generates highly cytotoxic reactive oxygen species (ROS) under light irradiation. ROS including singlet oxygen ( 1 O2), superoxide anion radical (O2 -•) and hydroxyl radical (•OH) can induce tumor cell death through apoptosis and/or necrosis, and even tumor immunity. By intravenous injection of photosensitizers for accumulation in tumor tissue and local light exposure to tumor sites, PDT can selectively destroy tumor cells while damages to the surrounding normal cells and tissues are minimized. [41] This approach profits from being noninvasive and reduced side effects (e.g., radiation damage, drug toxicity) compared to conventional surgery, radiotherapy and chemotherapy.
Porphyrin and its derivatives are excellent photosensitizers for PDT and several of them have been approved for clinical trials. For porphyrin-based MOFs, the high porphyrin loading capacity and free diffusion of oxygen and ROS allow the highly efficient PDT due to their porous structures. Furthermore, the biocompatible and biodegradable characteristics of MOFs result in enhanced biosafety during PDT. Since the first report on porphyrinic NMOFs for potential tumor PDT by Lin et al. in 2014, [42] numerous porphyrin-based MOFs have been designed for PDT until now, and prototypical progress reports are summarized in Table 1 , Table 2 and Table 3 .
Enhanced photodynamic therapy
In general, the quantity of 1 O2 generated by photosensitizers upon light irradiation is the key factor for PDT effects, which can be regulated by the efficiency of intersystem crossing (ISC) from singlet state (S1) to triplet state (T1) of photosensitizers. [43] Interestingly, the introduction of heavy atoms into photosensitizers is well known to induce an enhanced effect on ISC, termed as "heavy atom effect". In porphyrin-based MOFs, the interactions between porphyrins and metal ions can improve the photodynamic properties of porphyrins on account of "heavy atom effect", and thereby increase the production of 1 O2. [40a] The first report on porphyrinic MOFs for PDT was the use of DBP-UiO nanoplatelets, which was assembled by 5,15-di(pbenzoato)porphyrin (DBP) as linkers and Hf 4+ as metal nodes (Figure 5 ). [42] DBP-UiO nanoplates had a high porphyrin loading capacity of 77 wt %, and showed at least twice as efficient 1 O2 production as free DBP. Correspondingly, DBP-UiO nanoplates presented highly enhanced PDT efficacy against human head and neck tumor cells (SQ20B) compared to free DBP. Therefore, the coordination of porphyrin linkers with heavy metal nodes in porphyrinic MOFs exhibited an enhancement on PDT, caused by the "heavy atom effect", and the same phenomenon was observed in other porphyrinic MOFs. [33d, 39, 44] For example, Gd-TCPP MOF nanosheets, which were linked by TCPP with Gd ions, showed an improved photosensitive activity compared to free TCPP. [33d] On the other hand, the encapsulation of porphyrins in MOFs can also enhance ISC together with the 1 O2 generation. Lei et al. encapsulated TMPyP into HKUST-1, and found that the narrowed S1-T1 energy gap of TMPyP caused by the interaction between the encapsulated TMPyP and Cu 2+ nodes enhanced the ISC from S1 to T1. As a result, TMPyP@HKUST-1 exhibited higher 1 O2 production capability compared to free TMPyP, and thereby induced higher phototoxicity to tumor cells. [45] To optimize the photophysical properties and PDT efficacy of porphyrin-based MOFs, the reduction of porphyrins to chlorins by the hydrogenation of the cross-conjugated double bond of porphyrin ring is also an effective strategy, which could result in a red-shift of absorption and an increase of the extinction coefficient. [46] Lin et al. showed the first chlorin-based NMOFs (DBC-UiO) which were synthesized by Hf 4+ nodes and 5,15-di(pbenzoato)chlorin (DBC), and found an enhanced PDT effect for colon tumors. [47] There was a 13 nm red shift in absorption and an 11-fold augment in the extinction coefficient of longestwavelength Q band. Consequently, DBC-UiO NMOFs exhibited three times as efficient as DBP-UiO NMOFs in the generation of singlet oxygen as well as much stronger PDT effect in dual colon tumor cell lines (CT26 and HT29). Therefore, using chlorins to construct NMOFs provides nanoplatforms for realizing highly efficient PDT owing to the improved photophysical properties of the reduced porphyrins.
Generally, the accumulation of photosensitizers in tumor tissues and further uptake by tumor cells facilitates an efficient PDT. It is well known that the size of NMOFs is of crucial importance during cellular uptake. [48] To date, many studies have reported to optimize the particle sizes of MOFs and further enhance PDT efficacy. For example, Zhou et al. synthesized PCN-224 with a particle size from 30 to 190 nm to investigate the effect of particle sizes on cellular uptake and PDT efficacy. [35d] These PCN-224 nanoparticles showed different cellular uptake by Hela cells, and the 90 nm-sized PCN-224 had a maximal cellular uptake amount determined by inductively coupled plasma mass spectrometry (ICP-MS). Furthermore, the PDT for Hela cells indicated that the 90 nm-sized PCN-224 induced 81% cell apoptosis after PDT treatment, which was much higher than that induced by other sized PCN-224, suggesting that the sizedependent cellular uptake of NMOFs determines PDT efficacy. with permission. [42] Copyright 2016, American Chemical Society.
Light-controlled photodynamic therapy
Controllable generation of 1 O2 is useful for enhancing PDT efficacy, which requires the release of cytotoxic 1 O2 only in tumor sites and less damage to normal cells and tissues. [49] Light, as an essential exogenous condition for PDT, has been utilized to control the generation of 1 O2 from porphyrin-based MOFs in PDT, and thereby enhance PDT efficacy and reduce toxic side effects. For example, Zhou et al. synthesized photochromic SO-PCN MOFs by the integration of photochromic switch molecule BPDTE (1,2-bis(2-methyl-5-(pyridin-4-yl)thiophen-3-yl)cyclopent-1-ene) into porphyrinic MOFs, and the SO-PCN MOFs showed a reversible control of 1 O2 production via a competition of energy transfer pathway upon specific wavelength irradiation. [36a] Here, the open and closed state of BPDTE can be reversibly transformed upon photoirradiation, resulting in different photophysical properties (i.e., diverse energy levels). In the SO-PCN MOFs, BPDTE upon irradiation at λ=365 nm induced the open state, and the energy transfer occurred from TCPP excited triplet state to 3 O2, stimulating the generation of 1 O2. However, the irradiation (λ>450 nm) triggered BPDTE transformation to the closed state, whose energy level was lower than that of TCPP triplet state, and thereby the energy transfer happened to the closed BPDTE, resulting in the quenching of 1 O2. Therefore, the introduction of BPDTE in porphyrinic MOFs could modulate 1 O2 regeneration and show great potential for controllable PDT.
However, the absorption spectra of porphyrins are mostly in visible light range, resulting in poor tissue penetration, and thereby limits for in vivo PDT with porphyrin-based MOFs. Nearinfrared (NIR) light has advantages over visible light including deeper tissue penetration, higher sensitivity and resolution, which makes it attractive in harvesting NIR light in porphyrin-based MOFs for NIR-triggered PDT. Some studies demonstrated that lanthanide-doped UCNPs can transform NIR light to visible light, and thereby excite the photosensitizers under NIR irradiation for enhanced PDT. [50] Recently, several studies reported the combination of porphyrin-based MOFs with UCNPs for NIR-triggered PDT to enhance therapeutic efficacy. [38d] Upon NIR laser irradiation, MOF-UCNP nanoparticles could produce 1 O2 and the yield increased with the loading of UCNPs. The results showed that less cell death was observed after 980 nm laser irradiation for PCN-224 without UCNPs, but a reduction in cell viability of 63.7% occurred after NIR irradiation for MOF-UCNP nanoparticles, which indicated a great potential of MOF-UCNP nanoparticles for NIR-triggered PDT.
Positive targeted photodynamic therapy
In general, nanoparticles have a passive targeting ability for improving accumulation at tumor site due to enhanced permeability and retention (EPR) effect. However, surface modification can configure nanoparticles with an active targeting ability, facilitating precise positioning of targeted site and promoting cellular uptake. Due to abundant functional groups and metal nodes on the surface, porphyrin-based MOFs can be easily modified by host-guest reactions, and now various porphyrinbased MOFs have been modified with targeting moieties for enhanced PDT. [35d, 36e, 51] Zhou et al. modified PCN-224 NMOFs with folic acid (FA), of which the receptor is overexpressed in tumor cells, [35d] through the coordination between carboxylate groups of FA and Zr6 clusters. The results showed that FA-modified PCN-224 NMOFs had better cellular uptake by FAR-positive Hela cells than PCN-224 NMOFs due to the FA receptor-mediated endocytosis, and further improved PDT efficacy against to Hela cells. Zhang et al. reported REVIEW hyaluronic acid (HA)-coated Zr(IV)-based porphyrinic NMOFs (PZM) for enhanced PDT due to the CD44-targeting of HA to CD44-overexpressed tumor cells. [51] The in vivo results confirmed that more HA-coated PZM NMOFs were distributed in CD44positive tumor sites compared to PZM NMOFs, and exhibited remarkable tumor growth inhibition.
In addition, modification of porphyrin-based MOFs with specific biomolecules, such as cell membranes, DNA and antibody, also provides an active targeting ability. [38d, 52] For instance, Zhang's group and Cheng's group decorated the porphyrin-based NMOFs with tumor cell membranes for immune escape and homologous targeting. [52b, 52c] Tumor cells possess the features of immune tolerance and tumor homologous binding, which are closely associated with their specific plasma membrane proteins. Interestingly, Zhao et al. established a universal method for DNA functionalization of MOFs via surface coordination chemistry, and further modified PCN-224 NMOFs with DNA aptamers (AS1411), which endowed PCN-224 NMOFs with specific molecular recognition capability for specific targeting of human breast cancer cells MDA-MB-231. [52a] 
Tumor microenvironment-associated photodynamic therapy
Porphyrins show great promising for PDT, but the oxygen dependence limits the therapeutic efficacy of PDT owing to the hypoxia phenomenon in most tumor cells/tissues. [53] Moreover, the oxygen consumption in PDT is faster than the oxygen supply by tumor blood vessels, which further aggravates hypoxia in tumor cells/tissues, and thereby decreases PDT efficacy. [54] To overcome hypoxia in tumor microenvironment, combining MOFs with other adjuvants (e.g., oxygen carriers, peroxidase and interference agents of oxygen consumption [51, 55] ) or using its own ingredients (e.g., Cu, Fe, Mn metal ions in MOF skeletons for Fenton-like reactions [56] ), is an efficient strategy to increase the intratumoral O2 level, and thereby achieve better therapeutic efficacy for PDT.
Ren et al. reported platinum-decorated PCN-224 (PCN-224-Pt) NMOFs for enhanced PDT (Figure 6 ). [39] Due to higher level of H2O2 in tumor microenvironment, Pt nanoparticles with catalase-like activity could catalyze the decomposition of intratumoral H2O2 to generate O2, which could facilitate the further generation of cytotoxic 1 O2 to kill tumor cells. In vitro results showed that PCN-224-Pt presented much higher lethality upon 638 nm laser irradiation than that of PCN-224 in the hypoxia conditions. In vivo antitumor potential of PCN-224-Pt in H22 tumor-bearing mice model confirmed that tumor growth was completely inhibited after the injection of PCN-224-Pt upon irradiation, but only partial tumor inhibition was observed for PCN-224 after PDT. Lin et al. proposed to use 5,10,15,20-tetra(pbenzoato)porphyrins (TBP) as linkers and Fe3O clusters as metal nodes for the synthesis of porphyrinic NMOFs (Fe-TBP), in which the Fe3O clusters could decompose the intratumoral H2O2 through Fenton reaction to produce more O2 for PDT and thereby effectively conquer cellular hypoxia. [56a] Compared to free TBP and Hf-TBP NMOFs constructed from Hf-based clusters and TBP linkers, Fe-TBP NMOFs showed highest PDT efficacy under both normoxic and hypoxic conditions. Obviously, Fe-TBP NMOFs are promising for enhanced PDT in hypoxia due to the use of inherent ingredients in porphyrinic MOFs without the addition of other adjuvant agents.
In addition, the increase of ROS level can be achieved by decreasing the glutathione (GSH) level in tumor cells, because GSH can weaken the ROS from the photosensitizers and further decrease PDT efficacy. [57] To decrease GSH level in tumor cells, Li et al. constructed metalloporphyrinic NMOFs (MOF-2) that assembled from Al 3+ nodes and TCPP(Cu) linkers. [58] As active center of MOF-2, Cu 2+ could specifically bind and absorb GSH followed by the decrease of GSH level, and thereby increase the ROS level. Compared to NMOFs without Cu 2+ center (MOF-1), MOF-2 has GSH-binding role and generated higher concentration of ROS. In vitro results showed that MOF-2 exhibited comparable therapeutic effect with antineoplastic drug camptothecin (CPT). It offers an interesting idea for controlling tumor microenvironment by directly decreasing intracellular GSH level to enhance PDT efficacy.
Specific tumor microenvironment-associated controllable 1 O2 release is also an attractive strategy for enhanced PDT. [59] For instance, Tang et al. developed a bimetallic porphyrinic MOF (NP-1), which could be activated to control 1 O2 release for PDT by hydrogen sulfide (H2S) signaling molecules in a colon adenocarcinoma tumor microenvironment. [59a] NP-1 was synthesized by the self-assembly of TCPP(Zn) linkers and Cu 2+ nodes. In vitro results showed that NP-1 NMOFs were activated by H2S in cells to induce apoptosis of tumor cells upon irradiation due to the Cu 2+ release from NP-1 NMOFs triggered by H2S in cells. In vivo antitumor results also demonstrated the high H2S levels in colon adenocarcinoma tumors significantly enhanced the antitumor efficacy owing to the H2S-responsive PDT.
More recently, Jiang et al. found that 2D Cu-TCPP MOF nanosheets exhibited selective generation of 1 O2 in tumor microenvironment and depletion of GSH, presenting the augmented tumor therapeutic efficacy. [60] Here, the TCPP linkers in nanosheets possess peroxidase-like activity in response to H2O2 and acidic pH in tumor microenvironment, and further reduced to peroxyl radicals (ROO· ) with the help of peroxidaselike Cu-TCPP MOF nanosheets and Cu 2+ ions. The 1 O2 could be generated in the spontaneous recombination reaction of ROO· according to the Russell mechanism. Furthermore, GSH could be depleted and converted into oxidized glutathione (GSSG) by the cycle conversion of Cu 2+ and Cu 1+ in Cu-TCPP MOF nanosheets. Consequently, Cu-TCPP MOF nanosheets selectively kill tumor cells without side effects both in vitro and in vivo. In this view, these therapeutic strategies based on tumor microenvironment are capable of avoiding oxygen dependence and light penetration limitation in PDT, offering some inspirations on tumor treatments. Reproduced with permission. [39] Copyright 2018, American Chemical Society.
Synergistic therapy of porphyrin-based MOFs
To date, numerous therapy modalities based on nanoplatforms, including chemotherapy, PDT, photothermal therapy (PTT), radiotherapy (RT), immunotherapy and gas therapy, have been developed as effective techniques for treating malignant tumors. [59c, 61] However, single therapy modality often fails to achieve ideal therapeutic efficacy due to suffering from some limitations, such as multidrug resistance, oxygen dependence, nonspecific heating, and serious side effects. Hence, much effort has been devoted to developing multifunctional nanoplatforms, which integrate two or more therapy modalities into a single system. Porphyrin-based MOFs exhibit excellent PDT efficacy due to the photophysical property of porphyrins, and porous structures endow them with controlled drug delivery. Furthermore, porphyrin-based MOFs can integrate other functional components to obtain multifunctionality. Hence porphyrin-based MOFs are able to combine with two or more efficient therapy modalities for tumor therapy, that can achieve synergistic effects for maximizing therapeutic efficacy.
Synergistic chemo-and photodynamic therapy
Combination of PDT and chemotherapy is an efficient dualmodality therapy that have shown enhanced therapeutic efficacy and negligible toxicity. [62] Here, PDT can generate toxic ROS in tumor cells/tissues that induces oxidative damage to intracellular protein and DNA, resulting in high sensitivity of tumor cells to toxic chemotherapeutic drugs. [56b, 63] Thus, the use of lower doses of chemotherapeutic drugs could bring desired antitumor effects with reduced toxic effect on normal cells/tissues. The open porosity, stable structure and low cytotoxicity of porphyrin-based MOFs allow them as drug delivery carriers to encapsulate chemotherapeutics, and the intrinsic nature of porphyrin-based MOFs supports satisfactory drug-release behavior to enhance therapeutic efficacy. [64] Hence, drug-loaded porphyrin-based MOFs show great potentials for synergistic chemo-and photodynamic therapy.
Yin et al. reported biocompatible zirconium porphyrinic NMOFs (NPMOFs) for synergistic chemotherapy and PDT. [37a] NPMOFs showed a doxorubicin (DOX) loading efficiency as high as 109% (w/w), which was attributed to the noncovalent interactions between DOX and NPMOFs, such as π-π stacking effects, hydrophobic interactions and electrostatic interactions. Drug release profiles showed a very slow DOX release rate in normal biological environment (only 10.3% of DOX release at pH 7.0 after 72 h), but a fast DOX release behavior in tumor microenvironment (58.5% of DOX release at pH 5.0 after 72 h). Such drug release behavior is beneficial for a high therapeutic efficacy against tumor cells and low side effect to normal cells. On the other hand, 59.8% of porphyrin in NPMOFs resulted in excellent PDT efficacy. 90% of tumor cell apoptosis was observed by synergistic therapy of DOX@NPMOFs upon 655 nm laser irradiation. In vivo therapy for HepG2 tumor-bearing mice achieved an enhanced therapeutic efficacy for DOX@NPMOFs compared to single chemotherapy or PDT, indicating biocompatible porphyrin-based MOFs are highly promising for synergistic chemotherapy and PDT.
For light-controlled release of toxic chemotherapeutic drugs and enhanced PDT, Zhang et al. developed core-shell composite nanoparticles (AuNR@MOFs) by the growth of porphyrinic MOFs on gold nanorods (AuNR) (Figure 7) , [38a] which was used for synergistic chemotherapy and phototherapy due to the welldefined pore structure as drug carrier, TCPP as photosensitizer and AuNR as photothermal agent. Using camptothecin (CPT) as a model drug, AuNR@MOFs achieved controllable CPT release by 808 nm laser irradiation. On the other hand, AuNR@MOFs exhibited an enhanced ability to produce 1 O2 compared to single porphyrinic NMOFs upon 660 nm laser irradiation due to the 10.1002/anie.201909880
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Synergistic photothermal and photodynamic therapy
Similar with PDT, PTT is also a targeted and local therapeutic way with minimal invasiveness and high efficacy, which uses the photothermal agents to generate heat upon NIR irradiation to ablate tumor cells and tissues. [41] Differently, PTT is an oxygenindependent and ROS-free process mediated by photothermal agents upon NIR irradiation. Hence, the combination of PDT and PTT for tumor treatment could synergistically enhance the therapeutic effect, and reduce side effects. [65] On one hand, appropriate heat generated by PTT can improve blood flow as well as oxygen supply, and thereby intensify sensitivity of tumor cells to oxygen-dependent PDT; on the other hand, the ROS produced by PDT can interfere with tumor physiology and change its microenvironment, and thereby increases heat sensitivity of tumor cells. [66] Recently, several studies on porphyrin-based MOFs for synergistic PDT and PTT have been reported. Zhang et al. proposed to assemble porphyrinic MOFs on polydopamine (PDA) nanoparticles to form core-shell nanoparticles (PDA@MOF), [38g] and the photodynamic activity of porphyrinic MOFs and photothermal effect of PDA nanoparticles could contribute PDT and PTT for tumors. The results indicated that PDA@MOF nanoparticles efficiently generated intracellular ROS upon irradiation with 630 nm laser, and had excellent photothermal conversion upon irradiation with 808 nm laser. Only 18% of cells viability was observed after the incubation with PDA@MOF nanoparticles and irradiation by 630 nm and 808 nm lasers, which was much lower than that by single laser irradiation, suggesting the synergistic tumor inhibition performance.
Besides composite porphyrinic NMOFs, porphyrinic NMOFs without the integration of other PTT agents also have been developed for synergistic PTT and PDT, which shorten the synthesis procedures and improve biosafety. For example, Yang et al. reported novel multifunctional metalloporphyrinic NMOF (Zr-FeP) shuttles for PDT and low-temperature PTT synergistic treatment. [66] Zr-FeP NMOFs were assembled from Zr6 clusters and TBP(Fe) metalloporphyrins and loaded with an inhibitor of heat shock protein 70 (Hsp70). The results demonstrated that Zr-FeP NMOFs enabled concurrently to catalyze endogenous H2O2 for the generation of abundant · OH due to Fenton effect of ion centers, and produced toxic 1 O2 upon laser irradiation. Furthermore, Zr-FeP NMOFs showed obvious photothermal effect and the photothermal conversion efficiency was up to 33.7%. Consequently, upon a 635nm laser irradiation, the Hsp70-10.1002/anie.201909880
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Recently, Li et al. proposed to use Cu-TCPP MOF nanosheets as phototherapy nanosystem for synergistic PTT and PDT. [67] The d-d energy band transition of Cu 2+ and the ultrathin characteristic enabled Cu-TCPP MOF nanosheets to have strong NIR absorption and excellent photothermal performance. The 808 nm photothermal conversion efficiency of Cu-TCPP MOF nanosheets was estimated to be 36.8% and 1 O2 could be generated upon 660 nm irradiation, which induced efficient synergistic PTT and PDT in vitro and in vivo.
Synergistic immuno-and photodynamic therapy
Immunotherapy has got important status in tumor therapy owing to the abilities to stimulate individual's own immune system to recognize and kill primary tumor cells as well as inhibit metastatic tumor cells. [68] Checkpoint blockade immunotherapy, which adopts antibodies or small molecules to block negative immune regulatory pathways for priming antitumor immune, has been successfully used in clinic. Studies have demonstrated that tumor cells themselves can induce T cell apoptosis via programmed cell death receptor 1 (PD-1)/programmed death 1 ligand (PD-L1) pathway for immune evasion. Consequently, PD-1/PD-L1 checkpoint blockade strategy is proposed to enhance antitumor immunity by inhibiting cytotoxic T lymphocytes exhaustion. However, such immunotherapy elicits confined rates of systemic antitumor response for many types of tumors according to insufficient activation of the host immune systems. [69] Interestingly, PDT can excite adaptive immune responses through releasing inflammatory mediators and cytokines into the intratumoral environment. Therefore, the combination of checkpoint blockade immunotherapy and PDT, can not only promote systematic immune response to inhibit the metastatic tumors, but also induce synergistic therapy for treating primary tumors. Recently, there are some reports describing porphyrinic MOFs for synergistic immunotherapy and PDT due to easy construction of porphyrinic MOFs-based nanoplatforms.
Zhang et al. reported benzoporphyrinic NMOFs (TBP-NMOF) for PDT, and further investigated synergistic PDT and α-PD-1 checkpoint blockade immunotherapy (Figure 8) . [70] TBP-NMOF was assembled by the coordination of tetrabenzoporphyrin linkers with 10-connected Zr6 clusters, which exhibited an efficient 1 O2 generation ability for PDT under the hypoxic microenvironment. The results demonstrated that TBP-NMOF-induced PDT could not only kill the 4T1 murine breast tumor cells, but also aggrandize the presentation of tumor-activated antigens, further stimulate adaptive immune response for initiating the secretion of inflammatory cytokines (IFN-γ, TNF-α) and recruiting tumorinfiltrating T cells (CD4 + , CD8 + ). Further, they investigated the antitumor effect of low O2-dependent PDT and α-PD-1 in vivo. With the injection of PD-1 antibody, TBP-NMOF-induced PDT can dramatically inhibit the growth of 4T1 tumors without body weight loss. Furthermore, the combination therapy was more efficient than only PDT in preventing tumor recurrence and remarkably prevented lung metastasis of 4T1 tumor for 22 days. Similarly, Lin et al. also utilized porphyrinic MOFs (Fe-TBP) and α-PD-L1 for synergistic PDT and immunotherapy. [56a] It is interesting that the Fe3O clusters in Fe-TBP NMOFs could overcome hypoxia by Fenton reaction and enhance immunogenic PDT for priming tumor immunotherapy.
Obviously, the use of porphyrinic MOFs for synergistic immuno-and photodynamic therapy has shown great potentials for therapy of many difficult-to-treat tumors and inhibition of metastatic tumor cells, because immunogenic PDT can prime tumor immunotherapy to promote the response rates, and thereby significantly promote immunotherapeutic efficacy. In addition to checkpoint blockade immunotherapy based on antibodies or small molecule agents, it can be imagined that the use of porphyrinic MOF platforms to combine PDT with other immunotherapeutic strategies would be attractive. [71] 
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Other synergistic therapy
RT, that uses ionizing irradiation such as X-ray to destroy localized solid tumors, is a common therapy modality in clinic. Numerous nanoplatforms containing high-Z elements, which are able to interact with ionizing radiation to produce photo/auger electrons and then produce reactive free radicals to destroy tumor cells, have been applied for radiotherapy of tumors. [72] Biocompatible and biodegradable porphyrinic MOFs are formed by the coordination of porphyrin linkers and metal nodes, which is ideal to introduce high-Z metal elements into MOFs for the usage in synergistic PDT and RT. Liu et al. reported Hf-TCPP NMOFs assembled by Hf 4+ and TCPP through a solvothermal process, [44] in which TCPP linkers exhibited good PDT ability, and Hf 4+ metal center as a high-Z element was served as a radio-sensitizer to enhance RT. Due to the enhanced ISC by heavy Hf 4+ nodes, Hf-TCPP NMOFs were extremely effective in producing 1 O2 upon 661 nm irradiation for PDT. In vivo results on 4T1 breast tumorbearing mice showed that synergistic PDT and RT with Hf-TCPP NMOFs greatly inhibited tumor growth and had enhanced therapeutic efficacy compared to PDT or RT alone.
Nowadays, gas therapy also has been developed for tumor therapy due to its negligible side effect and enhanced therapeutic efficacy. Various gaseous transmitters, such as hydrogen sulfide (H2S), nitric oxide (NO) and carbon monoxide (CO), can be utilized for gas therapy that can accelerate tumor cell apoptosis, prevent tumor cell proliferation, and selectively protect the activity and physiological function of normal cells. [73] Recently, Cheng et al. reported synergistic NO gas therapy and PDT to treat tumors based on L-arginine (L-Arg)-incorporated PCN-224 NMOFs (Figure 9) . [52c] Here, L-Arg, a natural NO donor, could release NO for gas therapy via oxidization of ROS, which provided by PDT process of PCN-224 upon 660 nm irradiation. In vitro MTT assay showed that the viability of 4T1 cells treated with L-Argincorporated PCN-224 was lower than that treated with PCN-224 upon 660 nm irradiation. Of special note, cell apoptosis assay executed by flow cytometry showed L-Arg-incorporated PCN-224 had a considerable improvement of PDT under hypoxic condition compared to pure PCN-224, proving that NO can sensitize PDT in hypoxic tumors. Furthermore, in vivo antitumor study showed that the therapeutic efficacy of PCN-224 group was weaker than the L-Arg-incorporated PCN-224 group when irradiated under 660 nm light, indicating that synergistic PDT and gas therapy enhanced antitumor effects to a certain extent. Such nanoplatform with gas therapy and PDT provided a novel therapy paradigm to overcome the hypoxia barrier for efficient tumor treatment.
Hydrogen gas as clean energy has recently been discovered to have curative effects in many diseases, and it possesses huge potentials in tumor treatments due to its high biosafety and satisfactory therapeutic effect. He et al. developed a nanoscale Pd-MOF, which was assembled by Pd 2+ nodes and TPyP porphyrin linkers, for hydrogenothermal therapy of tumor. [74] Due to the strong hydrogen-binding and catalytic hydrogenation capacity of Pd, Pd-MOF could be used to deliver highly reductive hydrogen gas. The results showed that Pd-MOF possessed high hydrogen loading capacity and continuous hydrogen release profile. The photothermal experiments exhibited that Pd-MOF loaded with hydrogen gas possessed higher photothermal conversion efficiency (44.2%) than only Pd-MOF (27.7%) at 808 nm irradiation. Further in vitro and in vivo results proved the synergistic antitumor effects of hydrogen gas and PTT.
Interestingly, selectively cutting off the nutrient supply and metabolism pathways of tumor cells is another efficient strategy for tumor therapy. Zhang et al. designed a tumor targeted cascade bioreactor mem@catalase@GOx@PCN-224 (mCGP) by the encapsulation of glucose oxidase (GOx) and catalase in tumor cell membrane-camouflaged PCN-224 NMOFs for synergistic starvation and PDT. [52b] It was found that mCGP could facilitate microenvironmental oxygenation by catalyzing endogenous H2O2 to generate O2 by catalase, which would subsequently accelerate the consumption of intracellular glucose by GOx and increase the generation of 1 O2 under 660 nm irradiation. It could cut off tumor glucose supply and disturb glucose metabolism related cellular elements for starvation therapy as well as overcome the hypoxia issue for enhanced PDT.
In vivo experiments revealed that mCGP possessed a certain antitumor activity without 660 nm irradiation for its long-term starvation effects. On the other hand, mCGD showed a complete suppression of 4T1 tumor in the presence of 660 nm irradiation without obvious side effects, which might be attributed to the significant synergistic effects of PDT and long-term tumor starvation therapy.
10.1002/anie.201909880
Accepted Manuscript
Angewandte Chemie International Edition 
Imaging-guided therapy of porphyrin-based MOFs
Nanomaterials have been comprehensively studied as novel imaging agents or functional platforms for bio-imaging, which produce signals or enhance signal contrast at specific tissues. Bio-imaging enables the visualization, evaluation and quantification of biological processes at the molecular and cellular levels in a noninvasive mean, and show great potentials in the earlier disease diagnosis, on-going assessment of treatment process and optimization of disease therapeutic protocols. [23b] Therefore, the construction of imaging-guided therapy nanosystems by the integration of therapy modalities and bioimaging techniques, are promising to maximize the therapeutic efficacy through time-and position-resolved manners. [75] Over the years, porphyrin-based MOFs have been utilized as promising fluorescence imaging-guided therapy nanosystems owing to their excellent fluorescent property and therapeutic ability. In addition, imaging modes of porphyrin-based MOFs can be branched to magnetic resonance imaging (MRI), X-ray computed tomography (CT), photoacoustic imaging (PAI) and photothermal imaging (PTI) by employing metal nodes in MOFs, metal centers in porphyrin rings or incorporating other contrast agents in MOFs.
Fluorescence imaging-guided therapy
Fluorescence imaging has been a powerful imaging mode for both in vitro and in vivo imaging with non-invasion and high signal sensitivity, which relies on the properties of fluorophores that absorb the photo energy in a certain band of wavelengths and then emit new photon energy in a band of longer wavelengths. Fluorescence imaging is rapid and suitable for high-throughput screening. [76] Porphyrins as popular fluorophores have been incorporated into MOFs for both in vitro and in vivo fluorescence imaging. [52a, 77] The use of fluorescence imaging to guide therapy allows the visualization of distribution and evolution of the tumor/particle during treatments, and thereby ensures selectively controllable therapy with high efficacy and safety. Actually, fluorescence imaging-guided therapy nanosystems based on porphyrin-based MOFs can be easily constructed for efficient therapy due to the combination of fluorescence and photosensitivity from porphyrins.
In 2017, Yin et al. developed for the first time biocompatible porphyrinic NMOFs for fluorescence imaging-guided tumor therapy (Figure 10) . [37a] Porphyrinic NMOFs (NPMOFs) with a high TCPP content (59.8%) achieved efficient fluorescence imaging. The results showed that the fluorescence of TCPP was observed at 651 nm with a weaker shoulder peak at 710 nm when excited at 514 nm, but only one emission peak at 689 nm for NPMOFs. [78] Strong red emission and long Stokes shift of NPMOFs induced a high signal-to-noise ratio and resolution in fluorescence imaging due to the low excitation interference, autofluorescence and scattering light from the biological tissue. In mice mode, the absorption, distribution, metabolism, and excretion (ADME) processes of NPMOFs were observed by tracking fluorescent trajectory, indicating the biocompatibility of NPMOFs in mammals. Furthermore, in HepG2 tumor-bearing mice mode, in vivo fluorescence of NPMOFs clearly confirmed the distributions of NPMOFs in tumors with high resolution and signalto-noise ratio, suggesting that porphyrinic NMOFs are promising as fluorescence imaging-guided therapy platforms for earlier tumor diagnosis and enhanced therapy. On the other hand, composite porphyrinic NMOFs have also been constructed for fluorescence imaging-guided therapy. [38a, 79] For example, Zhang et al. assembled porphyrinic NMOFs on AuNR to form core-shell nanocomposites for fluorescence imaging-guided PDT, PTT and chemotherapy. [38a] The introduction of porphyrinic NMOFs endowed the nanocomposites with the abilities of PDT, chemotherapy and fluorescence imaging, while AuNR exhibited excellent PTT ability.
In addition, fluorescence imaging-guided therapy can also real-time monitor and assess the therapeutic efficacy according to the changes of fluorescence signals, and further improve the therapeutic efficacy and avoid under-or over-treatment. Lei 
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Angewandte Chemie International Edition REVIEW porphyrin@MOF nanoprobe, which was assembled by porphyrin (TMPyP), folate targeting-motif and a caspase sensitive fluorescent dye, i.e., Cy3-labelled caspase-3 substrate peptide into MOFs. [45] Here, the fluorescence of Cy3 quenched until the activated caspase-3 to specifically cleave the peptide and the Cy3 released from MOFs for fluorescence imaging, resulting in a caspase-responsive sensing strategy for monitoring cell apoptosis. These results demonstrated that biocompatible TMPyP@MOFs possessed enhanced 1 O2 yield and folate targeting tumor therapy as well as the ability for in situ imaging of therapeutic efficacy via caspase-3 activation. The switch-on signal provides an effective way to image intracellular caspase activity for real-time monitoring and evaluation of treatment effects. 
MRI-guided therapy
MRI is another noninvasive medical method to obtain high spatial resolution images of human anatomy and physiological processes. It utilizes an external magnetic field to detect radiofrequency signals produced from protons, typically of hydrogen atoms in water from fat and tissues. The acquired signals can be utilized to compare different tissues, distinguish lesions from healthy tissues, and build the anatomical maps of human body. [80] Compared to fluorescence imaging, MRI possesses the advantages of better spatial resolution, higher soft tissue contrast and unconfined penetration depth, but exhibits the disadvantage of low sensitivity. MRI contrast agents are typically used to reduce proton relaxation times and further improve the image quality. For porphyrin-based MOFs, the metal nodes of MOF skeleton, the chelation of paramagnetic metal ions in porphyrin rings or the incorporation of other contrast agents in MOFs make MRI-guided therapy possible.
Recently, Wang et al. reported that gadolinium porphyrinic NMOF sheets (Gd-TCPP) possessed high relaxation rate (40.8 mM -1 s -1 ) and 1 O2 production upon 660 nm irradiation due to high Gd 3+ content in MOFs and TCPP photosensitizers. [33d] Therefore, Gd-TCPP nanosheets are potent for T1-weighted MRI-guided PDT. Yin et al. proposed to chelate paramagnetic metal ions into porphyrin rings to develop metalloporphyrinic MOFs for T1weighted MRI-guided therapy. [81] By chelating paramagnetic Mn ions into porphyrin rings, metalloporphyrinic MOFs possessed excellent T1-weighted MR contrast capacity and high photothermal conversion and heat-responsive NO release. In vivo experiments showed that metalloporphyrinic MOFs were efficiently accumulated at tumor site after intravenous injection into mice by MRI, and the tumor was completely inhibited when exposed to 808 nm laser for PTT and NO gas therapy, indicating the potential for MRI-guided therapy.
Multi-mode imaging-guided therapy
Single-mode bio-imaging is usually short of capabilities for comprehensive imaging and cannot provide entire characteristics for diagnosis of diseases due to its inherent limitations, such as limited signal sensitivity, tissue penetration depth and spatial resolution. To overcome these problems, various studies have concentrated on the construction of multi-mode imaging behaviors into a single MOF-based system. [82] For porphyrinic MOFs, the use of functional components of MOFs themselves or assembling other imaging agents can achieve multi-mode imaging-guided therapy systems, which could avoid inherent limitations of single imaging-guided therapy and provide more accurate positioning of lesions/particles as well as guidelines of therapy.
For example, Yin et al. developed a biocompatible nanocomposite (Fe3O4@C@PMOF) with fluorescence imaging and MRI functions for dual-mode imaging-guided phototherapy (Figure 11) . [79] Specifically, Fe3O4@C cores were selected as T2weighted MRI contrast agents and photothermal agents, and porphyrinic MOF shells had fluorescence imaging and PDT abilities. Such dual-mode imaging nanoplatforms achieved high sensitivity of fluorescence imaging as well as deep penetration and great spatial resolution of MRI, and more precise in vivo information can be provided for enhancing the safety and therapeutic efficacy. After intravenous injection of Fe3O4@C@PMOF nanocomposites in MCF-7 tumor-bearing mice for 22 h, the fluorescence imaging showed that nanocomposites were primarily localized in the liver region than other organs. The tumor area was slowly brightened and became the brightest site in the mice after 26 h, indicating that the REVIEW accumulation of nanocomposites at tumor site was gradually increased. The results were also confirmed by dramatic dimming at tumor site in T2-weighted MR imaging. Motivated by their high tumor accumulation, Fe3O4@C@PMOF nanocomposites were used for imaging-guided phototherapy, and exhibited obvious PTT/PDT synergetic effect for MCF-7 breast tumor but low toxicity for normal tissues.
Clearly, it is also valuable to develop porphyrinic MOFs without additional components for multi-mode imaging-guided therapy due to its simplicity and efficiency. Wu et al. reported ultrathin 2D Cu-TCPP MOF nanosheets for dual-mode imagingguided phototherapy. [67] The Cu 2+ nodes in Cu-TCPP nanosheets offered excellent photothermal performance for PTT, PTI and T1weighted MRI. Meanwhile, porphyrin TCPP provided the ability to produce 1 O2 for PDT. The results indicated that Cu-TCPP nanosheets had huge potentials for synergistic PTT and PDT, guided by PTI and MRI.
CT is an important medical imaging technique, which is attributed to attenuation of X-rays by a specimen to offer 3D images with high spatial resolution. [83] The high-Z number elements in MOFs can be chosen as CT contrast agents. In addition, PAI is a recently developed imaging technique that integrates optical excitation and ultrasound detection, [84] and shows the superiority of high selectivity and deep penetration, and can acquire high resolution and strong contrast tissue images. To combine the merits of PTI, CT and PAI, Yang et al. developed multifunctional metalloporphyrinic NMOF (Zr-FeP) shuttles as an "all-in-one" nanoplatform to realize tri-mode imaging-guided therapy. [66] In vivo PAI experiments demonstrated that much stronger PA signal was accepted in the tumor tissue after tail vein injection of nanoshuttles into mice for 2 h, indicating the considerable tumor accumulation of nanoshuttles. Zr-FeP MOF nanoshuttles exhibited good CT capability due to the high-Zr component for CT imaging. Additionally, the outstanding photothermal performance of Zr-FeP MOF nanoshuttles endowed remarkable PTI ability in vivo, and after treatment with Zr-FeP MOF nanoshuttles the tumor site temperature rapidly raised by 17 °C upon exposure to 635 nm laser for 5 min. Therefore, the fascinating tri-mode imaging capability of Zr-FeP MOF nanoshuttles would be a powerful tool for precise tumor diagnosis and imaging-guided therapy. [79] Copyright 2017, Nature Publishing Group.
Biosensing
A large number of physiological species play a key role in regulating cellular functions and physiological activities, of which the changes in the concentrations and types indicate disruptions or pathological changes in physiological environments. Therefore, the specific and sensitive biosensing systems have been increasingly used to detect and monitor the variations for disease diagnosis and biological processes in living organisms. Porphyrins and their derivatives have been widely studied as small molecule biosensors, due to their excellent physicochemical characteristics that can be used for signal interaction with host molecules. Moreover, porphyrins can mimic many biological functions. For example, porphyrins can reversibly bind with gaseous compounds and can operate photophysical and/or redox processes mediated by the target analytes. [8a] Interestingly, hemin, which also called iron protoporphyrin IX, has been utilized for biosensing, because it can act not only as a redox mediator based on the electrochemical activity of Fe (III)/Fe (II) reversible redox, but also as a catalyst based on the peroxidase-like activity. In recent years, MOFs have also been extensively employed to construct biosensors due to their unique merits. [17b, 76a, 85] Especially, the porous structure and high specific surface area of MOFs provide high catalytic activity for target molecules. In addition, the designed shape and size as well as specific chemical interactions between guest molecules and MOFs endow them with high selectivity over target molecules. Incorporating porphyrins into MOFs can remit self-quenching of porphyrins and realize the collection of multiple functionalities of MOFs and porphyrins for biosensing with high sensitivity, resolution and precision. To date, porphyrin-based MOFs have been utilized for biosensing applications including electrochemical (EC), fluorescence, photoelectrochemical (PEC), electrochemiluminescence (ECL) and colorimetric biosensors. Various studies have demonstrated the possibility of the porphyrin-based MOFs-based biosensors for detecting different biological substances and states, mainly including biomacromolecules, small molecules, ions, pH values and others. Some typical examples of porphyrin-based MOFs for biosensing are summarized in Table 1 -3.
Biosensing of biomacromolecules
DNA is the most vital genetic material of living beings, and various strategies have been proposed to detect DNA for diagnosis of diseases and biological processes. Among these strategies, EC biosensing has been extensively adopted for the 10.1002/anie.201909880
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Angewandte Chemie International Edition REVIEW detection of specific DNA owing to the high sensitivity and selectivity. [85] For DNA electrochemical biosensors, porphyrinbased MOFs with excellent electrocatalytic activity can be utilized as outer probes for the production and amplification of electrochemical signal. [26d, 86] For example, due to the peroxidaselike catalytic activity of TCPP(Fe) metalloporphyrins, Lei et al. encapsulated TCPP(Fe) into HKUST-1 and subsequently conjugated with streptavidin (SA) to construct an smart signaltransduction platform for hairpin DNA detection (Figure 12A-C) . [86a] Here, a label-free electrochemical DNA biosensor was designed by using TCPP(Fe)@MOF-SA as a signal probe and allosteric switch of hairpin DNA. The allosteric switch of hairpin DNA on the glassy carbon electrode (GCE) surface could form SA aptamer, that selectively binds the synthetic TCPP(Fe)@MOF-SA via biorecognition affinity. Thus, the conjugated TCPP(Fe)@MOF-SA on the GCE surface as mimetic catalyst could greatly enhance the oxidation of o-phenylenediamine (o-PD) to 2,2'-diaminoazobenzene in the presence of H2O2, as a fine electrochemical signal readout indicator. Such "signal-on" electrochemical biosensor has been proved to detect hairpin DNA with a detection limit down to 0.48 fM (S/N = 3), 6-order magnitude linear range and good feasibility in complex serum matrixes.
On the other hand, porphyrinic MOFs for fluorescence biosensing has also been developed for DNA detection by utilizing the fluorescence quenching mechanism. [33c, 87] For example, Wang et al. used ultrathin Cu-TCPP MOF nanosheets to design a fluorescence biosensor for rapid, sensitive, and multiplex detection of DNAs. [87] Due to the large surface area and large number of accessible active sites on the nanosheets, three dyelabeled ssDNA probes could be easily absorbed on the surface, leading to fluorescence quenching of the dye-labeled ssDNA by Förster resonance energy transfer (FRET). When specific target was hybridized with the ssDNA probes to form dsDNA, the formed dsDNA detached from Cu-TCPP MOF nanosheets owing to the weak physical adsorption between Cu-TCPP MOF nanosheets and dsDNA, and thereby the fluorescence "turn-on". Consequently, Cu-TCPP MOF nanosheets presented a great ability to quantitatively detect pathogenic DNA with detection limit in pM level.
Immunoassay is of great interest for the clinical early diagnosis of various tumors, such as prostate specific antigen (PSA) analysis for diagnosis of prostate cancer. PEC bioanalysis is a potential bioanalytical method based on the photoinduced electron transfer (PET) processes among analyte, photoactive species and electrode with photoirradiation, which has been widely used in the detection of various biological molecules. Recently, Zhang et al. reported a new non-enzyme PEC immunoassay using DNA-mediated nanoscale PCN-222 to detect PSA. [88] The ss-DNA-tagged antibody (Ab-DNA) was conjugated on PCN-222 to form Ab-DNA-functionalized NMOFs complex (Ab-DNA-NMOFs). Ab-DNA-NMOFs, as an active photocathode PEC substrate, presented a remarkably enhanced photocurrent response with the presence of dopamine (DA) on O2-containing aqueous media. Further functionalized with polyamidoamine dendrimer, Ab-DNA-NMOFs could serve as an efficient PEC signal transduction system for non-enzyme PSA immunoassay with hypersensitivity, with a broad calibration range of 1 pg mL −1 to 10 ng mL −1 and a detection limit of 0.2 pg mL −1 .
In addition, ECL, an electrochemical redox-induced light emission, possesses several advantages including low background interference, simple operation, high sensitivity and space-time controllability. Han et al. proposed to use porphyrin@MOFs for PSA sensing via ECL strategy. [89] In this study, Fe-MIL-88 MOFs were used as a platform to load hemin and gold nanoparticles (Au NPs) and further graft G-quadruplex DNAzyme for synergetic catalytic amplification of luminol. The pDNA-Au-Hemin-MIL-DNAzyme probes were acted as quenchers and enhancers in fabricating a target-induced ratiometric ECL biosensor for PSA detection. The results demonstrated that pDNA-Au-Hemin-MIL-DNAzyme-based biosensor exhibited highly sensitive and accurate analytical property for PSA with a linear detection range from 0.5 to 500 ng mL -1 and a detection limit of 0.058 ng mL -1 (S/N = 3).
Enzymes and proteins play important roles in the metabolic regulation, cell growth and other biological processes. Some of these biomolecules have been accepted as important biomarkers for early stage diseases diagnosis, prognosis judgement and pathogenesis study. Several different types of porphyrin-based MOFs have been used in the construction of electrochemical biosensor to enhance electrochemical signal for enzyme or protein biosensing. Yuan et al. reported multifunctional heminencapsulated Fe-MIL-88 MOFs, which were the first example in construction of an electrochemical aptasensor for thrombin (TB) detection (Figure 12D-F) . [26c] Such porphyrin@MOFs were served as support for the immobilization of recognition molecules (thrombin binding aptamer (TBA)), as well as conjugated with GOx for signal amplification. GOx could oxidize glucose into gluconic acid accompanied by the production of H2O2, which could be further electrocatalyzed by hemin to amplify the electrochemical signal. Such electrochemical biosensor showed a relatively low detection limit of 0.068 pM and a wide linear ranged from 0.0001 nM to 30 nM with a high correlation coefficient of 0.9961, indicating that the constructed biosensor could be used to detect TB quantitatively. Lei et al. designed an electrochemical biosensor that was composed of iron metalloporphyrinic NMOFs (PorMOF) for telomerase activity detection. [90] PorMOF exhibited an excellent electrocatalytic activity towards O2 reduction, which induced to detect telomerase with a detection limit of 30 cell mL -1 and assess the telomerase activity even in single Hela cell. Moreover, porphyrin-based MOFs were also applied to construct PEC and ECL biosensors for protein detection. For example, Zhang et al. developed a simple PCN-222 based PEC biosensor for label-free detection of a phosphoprotein (α-casein). [91] Shan et al. utilized zinc metalloporphyrinic MOFs (MOF-525(Zn)) to develop an ECL biosensor for highly sensitive protein kinase A (PKA) activity assay. [92] 
Biosensing of small molecules
Various porphyrin-based MOF biosensors with peroxidaselike activity have been developed for detection of H2O2 and glucose, which are important biological indicators in clinical medicine. For instance, Liu et al. synthesized MIL-101(Al)-NH2 MOFs to anchor hemin for the formation of H@M composites, which showed peroxidase-like activity capable of catalyzing oxidation of the peroxidase substrate 3,3,5,5tetramethylbenzidine (TMB) by H2O2 to produce the blue color in solutions. [93] Thus, H@M composites offered a simple, sensitive and selective colorimetric approach for H2O2 determination, and the results showed that H2O2 could be measured as low as 2 μM and the linear range was from 5 μM to 200 μM with a correlation coefficient of 0.997. Furthermore, by introducing GOx as a catalyst into H@M composites for oxidation of glucose, a MOFbased colorimetric biosensor was constructed for quantitative analysis of glucose in aqueous solution. The glucose biosensing was observed to have a linear range from 10 μM to 300 μM with a correlation coefficient of 0.996.
Monitoring and quantifying some of gas levels (e.g., O2, H2S) in living cells are of great importance in clinical medicine, because the gas concentrations are correlated with many human physiological and pathological processes. For example, Lin et al. developed novel phosphorescence/fluorescence dual-emissive NMOFs (R-UiO) for ratiometric intracellular O2 quantification (Figure 13) , [36b] which was the first example of MOFs-based intracellular O2 biosensor. R-UiO NMOFs were synthesized by the coordination of Pt(II)-porphyrin linkers DBP(Pt) as an O2-sensitive probe and amino-functionalized quaterphenyldicarboxylate linkers (QPDC-NH2) with Hf ions, and then covalently attached with Rhodamine B isothiocyanate (RBITC) as an O2-insensitive reference probe via thiourea bonds. The DBP(Pt) and RBITC shared the same excitation energy, but the phosphorescence/fluorescence emissions did not interfere with each other, which allowed for the determination of intracellular O2 levels. When mouse colon carcinoma CT26 cells were treated with R-UiO NMOFs under different O2 pressure (pO2) conditions at 4 mmHg, 32 mmHg and 160 mmHg, which represented hypoxia, normoxia and aerated conditions respectively, the analytic data by ratiometric luminescence images were 5.1±2.5 mmHg, linkers as heterogeneous fluorescence probe for the sensing of H2S in living cells. [94] The Cu 2+ centers in MOF frameworks induced the fluorescence quenching of TCPP porphyrins, which could be used as H2S-responding site for fluorescence "turn-on" sensing of H2S. Consequently, this biocompatible fluorescence probe exhibited high selectivity and sensibility as well as low toxicity in in situ sensing of H2S under a physiological environment.
As a biochemical messenger, DA plays a critical role in neurotransmitters and neuromodulators in organisms that affects human activities. For measuring DA release from living cells, Yamauchi et al. designed an electrochemical biosensor using composite porphyrinic MOFs (MOF-525-PEDOT NTs), [95] which was made up of conductive poly(3,4-ethylenedioxythiophene) nanotubes (PEDOT NTs) coated with MOF-525 nanocrystals. The synergistic conductivity and catalytic performance of MOF-525-PEDOT NTs enhanced the detection ability for DA with a linear concentration range (2 μM~270 μM) and detection limit (0.04 μM).
Nowadays, rapid and sensitive detection of organophosphorus pesticides has gained more and more attentions due to the environmental pollution and human health risks. Su et al. synthesized Cu-H MOFs/NECF composites by ballflower-like Cu-hemin MOFs grown on the fibers of 3D nitrogencontaining melamine carbon foam (NECF) and the immobilization of AChE on Cu-H MOFs/NEC for trichlorfon detection. [96] The Cu-H MOFs/NECF-based biosensor exhibited great performance for trichlorfon detection with a board linear range (0.25~20 ng mL -1 ), low detection limit (0.082 ng mL -1 ) as well as good toughness, and thereby facilitated trace detection of organophosphorus pesticides.
Ion sensing
Several metal ions are essential elements in human body and play vital roles in cellular activities, while their excesses would be harmful for health. Especially, heavy metal ions are easy to accumulated in human body via the food chain, and thereby result in adverse effects. Obviously, it is of great importance to selectively detect metal ions in cells or in environments. For porphyrin-based MOFs, the coordination capability of metal ions in porphyrin rings endows them with the ability to construct fluorescence "turn-off" or "turn-on" biosensors. In 2013, Li et al. proposed to use porphyrinic MOF-525 as a fluorescence "turn-off" biosensor for Cu 2+ sensing. [97] The porphyrin moieties in MOF-525 provided accessible recognition sites for fluorescence quenching response to trace amount of Cu 2+ ions due to energy/charge transfer process. MOF-525 fluorescent probes showed great potentials for rapid and specific detection of Cu 2+ in practical water samples and copper-related diseases likes Wilson and Alzheimer's diseases. Recently, a novel fluorescent porphyrinic MOF probe, where the UiO-66(OH)2 MOF was encapsulated into PCN-224, was developed by Lu et al. for detecting Cu 2+ in complex water environments. [98] Similarly, due to the fluorescence quenching ability of Cu 2+ to the probe, this fluorescent probe exhibited excellent Cu 2+ detection ability with a LOD value as low as 0.068 nM, which is better than the Cu 2+ concentration limitation in drinking water regulated by WHO.
Compared to fluorescence "turn-off" biosensors, fluorescence "turn-on" biosensors can avert the wrong response to sensing signals and more conveniently identify in a dark background. [36c] For example, Jiang et al. developed a fluorescence "turn-on" biosensor based on Pd(II) metalloporphyrinic MOFs (PCN-222(Pd)) for Cu 2+ sensing. [99] Here, PCN-222(Pd) was used as catalytic Heck reaction system to produce highly fluorescent "turn-on" signal in the presence of Cu 2+ , due to a stronger binding affinity of Cu 2+ over Pd 2+ to the nitrogen atoms in the porphyrin and the conversion of nonfluorescent aniline to fluorescent ring-closing product via Pd 0catalyzed Heck-reaction. Consequently, PCN-222(Pd) biosensor 10.1002/anie.201909880
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Angewandte Chemie International Edition REVIEW exhibited highly selective and sensitive sensing of Cu 2+ in aqueous environments with a very low detection limitation. In addition, porphyrinic MOFs were also utilized in construction of electrochemical biosensors for detecting metal ions. [100] Additionally, although anions sensing is more challenging, selective sensing of anions by porphyrin-based MOFs has also been reported. For instance, Cao et al. developed Zr-based MOFs with the mixed-linkers of 1,3,6,8-tetra (4-carboxylphenyl) pyrene (TBAPy) and TCPP (Zr(TBAPy)5(TCPP)), as a fluorescence "turnon" biosensor for S 2− sensing in aqueous environments. [36c] The results showed that the fluorescent intensity of Zr(TBAPy)5(TCPP) was intensified remarkably after adding S 2− , but other anions including SO4 2− , CNS − , COOH − , Br − , I − , IO3 − , F − , HSO3 − , Cl − and NO3 − did not alter its fluorescent intensity. Eddaoudi et al. encapsulated TMPyP(Pt) porphyrins into rho-ZMOF for selectively sensing of various anions in aqueous and methanolic solutions. [8c] 
pH sensing
Generally, pH plays an important role in maintaining the stability, normal morphology and function of cells and organisms. Due to the spectral characteristics changed by protonation/deprotonation of the pyrrole ring in porphyrins under varied pH, [101] porphyrin-based MOFs could be used to construct pH sensors, showing great potentials in pH monitoring, disease diagnosis and even evaluating therapeutic efficacy. In 2013, Zhou et al. reported for the first time Zr-based porphyrinic MOF PCN-225 and metalloporphyrinic MOF PCN-225(Zn) for pH sensing. [35b] The results demonstrated that the fluorescence intensity of PCN-225 has a strong correlation with pH value of the solution when the pH in the range of 0~10.2, and the most acidic solution showed the weakest fluorescence while the pH 10.2 solution gave the highest intensity. Furthermore, 7~10 was the most sensitive pH range for intensity response. Lu et al. developed an effective dual-emission fluorescent MOF composite probe (RB-PCN) that constructed by the encapsulation of Fe3O4 nanoparticles into PCN-224 and following a modification with RBITC. [102] The results showed that RB-PCN could sensitively detect a board range of pH changes, and could also monitor the pH changes in living cells by fluorescence confocal imaging and determine the pH values in actual water samples by fluorescence spectra.
Other applications of porphyrin-based MOFs
In addition to the biomedical applications as mentioned above, porphyrin-based MOFs also have valuable applications in other biological related fields. For example, Guo et al. synthesized spherical Cu-TCPP(Cu) MOFs, and subsequently encapsulated Ag nanoparticles into MOFs to form Ag/Cu-TCPP(Cu) composites for antibacterial application. [103] The results showed that antibacterial effect of Ag/Cu-TCPP(Cu) composites was superior to that of penicillin, and the cytotoxicity of Ag/Cu-TCPP (Cu) composites was lower than that of naked Ag nanoparticles and Ag ions in vitro. Furthermore, Ag/Cu-TCPP(Cu) composites could also significantly promote the wound healing in vivo.
More recently, Qu et al. utilized ultrathin Cu-TCPP(Fe) MOF nanosheets to physically adsorb GOx for constructing a composite nanocatalyst for in vivo wound healing. [104] Here, Cu-TCPP(Fe)/GOx could continuously convert nontoxic glucose into gluconic acid and H2O2 by GOx, following by the pH decrease from 7 to 3~4 that could dramatically activate the peroxidase-like activity of Cu-TCPP(Fe) MOF nanosheets. Subsequently, the produced H2O2 could be further transformed to the toxic •OH by the Fenton reactions of Cu and Fe ions. In vitro and in vivo experiments showed such cascade catalytic conversion from nontoxic glucose to toxic •OH enabled Cu-TCPP(Fe)/GOx nanocatalyst with robust antibacterial effect and negligible biotoxicity.
Toxicity and safety concerns
Regarding of the porphyrin-based MOFs for biomedical applications, the probable toxicity of porphyrin-based MOFs needs to be highly concerned. Considering the construction of MOFs from metal nodes and organic linkers, it is a priority to choose non-toxic or hypotoxic building components for improving the biocompatibility and reducing the toxicity. Fortunately, porphyrins as biocompatible motifs are beneficial for the improvement of MOFs' biosafety. However, the toxicity of MOFs was found to be closely related to their metal nodes. [76a] The biocompatible metal ions (e.g., Zr, Fe, Zn, Cu) are possible to be nodes for constructing friendly porphyrin-based MOFs due to their acceptable toxicity for biomedical applications. [106] Especially for the synthesis of composite porphyrinic MOFs, the additional functional components also need to be considered for potential threats to the tissues and organismis. In addition to the composition of porphyrin-based MOFs, the physicochemical natures of MOFs including size distribution, shape, surface chemistry and dose-depending properties are also important factors in terms of toxicology. [106] [107] All these parameters strongly affect the absorption, distribution, metabolism and excretion, biodegradation and clearance of porphyrin-based MOFs, and further determine their potential toxicity in vivo. To date, these aspects of porphyrin-based MOFs have not been fully investigated while the multifunctionality have been deeply explored in most biomedical studies.
Understanding the intricate interactions between the physicochemical property, biological performance and biosafety could contribute to the successful translation to practical biomedical applications. Therefore, the relevant studies of porphyrin-based MOFs in biomedical applications need to be developed in depth. Firstly, it is important to fully use various progressive characterization techniques to accurately determine the physicochemical parameters of MOFs (e.g., size, shape, surface chemistry, porosity) and reasonably evaluate their merits and limitations, for understanding and ultimately modulating the structure-function relationship for MOFs. [108] Next, investigating the correlation between MOFs and biological systems is the base of correlating the MOFs' features with the toxicity results. Recently, Faria et al. proposed the MIRIBEL (Minimum Information Reporting in Bio-Nano Experimental Literature) standard for REVIEW different studies on bio-nano interactions, which normalizes material characterization, biological characterization and experimental details for enhancing reproducibility and quantitative comparisons of bio-nano materials. [109] In the development of porphyrin-based MOFs for biomedical applications, such standard should be referenced to facilitate safety evaluation and material optimizations. Furthermore, great progress has been made with respect to mechanism-based hazard assessment of nanomaterials and advanced tools have emerged for their safety evaluation. [110] Therefore, not only for porphyrin-based MOFs, researchers need to accelerate the use of emerging methods and tools, combining research results with bioinformatics, to scientifically and quantitatively correlate the data outcome of biomaterials and their toxicity results for their practical applications in biomedicine.
Conclusions and perspectives
Porphyrins and their derivatives have been often used as photosensitizers for PDT, fluorophores for fluorescence imaging and sensors for biosensing due to their excellent photophysical properties. As a new type of porous materials, MOFs possess high porosity, tunable structure, multifunctionality, biocompatibility and biodegradability. Studies have demonstrated that the construction of porphyrin-based MOFs can not only overcome the limitations of free porphyrins like instability and self-quenching issues in physiological environments, but also integrate the functionalities of MOFs and porphyrins as well as improve the physicochemical properties. In this review, recent achievements and progresses on the construction of porphyrin-based MOFs and their biomedical applications have been highlighted and discussed.
To date, various methods have been used to construct porphyrin@MOFs, porphyrinic MOFs and composite porphyrinic MOFs in order to meet the requirements of biomedical applications. Among them, many strategies including heavy atom substitution of porphyrinic MOFs, controlling the particle sizes, controllable design and modification with targeting moieties or functional components were proposed to enhance therapeutic efficacy of porphyrin-based MOFs in PDT. Additionally, rational design of functional ingredients in MOFs or adjuvant agents enable interfere survival mechanisms and alter tumor microenvironment to achieve better results in terms of PDT efficacy. Obviously, the optimized construction of porphyrinbased MOFs shows great potentials for enhanced PDT of tumors.
Another efficient strategy for enhancing therapeutic efficacy is the implementation of multi-modality therapy in a single system to overcome the limitations of single modality therapy. Porphyrinbased MOFs have exhibited a great capacity of combining PDT with other therapy modalities, including chemotherapy, PTT, immunotherapy and gas therapy, to achieve synergistic effects for maximizing therapeutic efficacy and improving safety. However, the majority of current studies focuses on dual-modality therapy, but there are few reports on tri-or more modality therapy based on porphyrin-based MOFs, which might offer more significant therapeutic effects.
Porphyrin-based MOFs have also been developed for imaging-guided therapy to further optimize the therapeutic process and thereby enhance therapeutic efficacy. Due to excellent fluorescent property and photosensitization of porphyrins, porphyrin-based MOFs could realize fluorescence imaging-guided therapy. On the other hand, metal nodes in MOFs or the incorporation of contract agents in MOFs endow porphyrinbased MOFs with the ability of MRI-, CT-, PAI-or PTI-guided therapy. Such "all in one" nanoplatforms provide more accurate diagnosis and guidance for treatment, and are of great attractive for tumor therapy.
Besides the exploration of tumor therapy functions, porphyrin-based MOFs have been utilized to construct biosensors for detecting various biological ingredients, such as biomacromolecules, small molecules, ions, pH values and gases. Owing to the combination of excellent physicochemical natures of MOFs and porphyrins, porphyrin-based MOFs types of biosensors show significant performance in biosensing with high sensitivity and selectivity, acceptable reproducibility, good stability and biocompatibility, and some porphyrins including hemin, TCPP and its metal derivatives are often used to construct porphyrin-based MOFs type of biosensors. However, it can be anticipated that the biosensing performance could further improved by seeking more interesting porphyrins. On the other hand, porphyrin-based MOF type of biosensors for cell sensing and in vivo sensing need to further investigate for the development of biosensors in living biological systems.
Despite the growing number of impressive progress reports on porphyrin-based MOFs, their development in biomedical applications is still at the early stage facing many challenges. For porphyrin@MOFs, the porphyrin loading capacity, premature leakage and self-quenching of porphyrins should be considered during the synthesis process. Actually, porphyrinic MOFs are more promising candidates for biomedical applications. However, the influence of size, shape, composition and surface chemistry of porphyrin-based MOFs on therapeutic efficacy and biosensing ability should be further optimized to meet the requirements of personalized therapy, diagnose and detection. On the other hand, design of "all in one" nanoplatforms based on composite porphyrinic MOFs would be an efficient strategy to enhance therapeutic efficacy in tumor therapy and biosensing ability. Actually, researchers should establish the straightforward synthesis protocols for those designed MOF materials, as the simpler the preparation, the more likely it is that the product will be relevant for biomedical applications in the real-world. Finally, it needs to re-emphasize that thoroughly and deeply investaging the correlation between the fundamental parameters of porphyrinbased MOFs and their biosafety including the pharmacokinetics, biodistribution, biocompatibility, long-term toxicity and clearance from the body, are crucial for possible clinical translations. In conclusion, porphyrin-based MOFs have presented great potentials for the applications in tumor therapy and biosensing, and more advancements and progresses in biomedical field will be achieved in the future. Table 1 . Typical examples of porphyrin@MOFs for biomedical applications.
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MOFs
Porphyrins Methods Biomedical applications Refs.
UiO-66 DTPP(Zn)-I2
In situ formation PDT [26a] UiO-66 TCPP In situ formation PDT [26b, 111] HKUST-1 TMPyP In situ formation PDT; fluorescence imaging [45] HKUST-1 TCPP(Fe) In situ formation DNA sensing [86a] HKUST-1 Hemin In situ formation Detection of H2O2, glucose [112] Fe-MIL-88 Hemin
In situ formation Detection of TB [26c] Fe-MIL-88 Hemin
In situ formation Detection of the FGFR3 gene mutation [26d] Fe-MIL-88 Hemin
In situ formation Immunoassay of PSA [89] Tb-MOF Hemin In situ formation Colorimetric immunoassay of AFP [113] TTA-UC MOF TCPP(Pd) In situ formation Ultralow-power in vivo imaging [77] rho-ZMOF TMPyP(Pt) In situ formation Anion-selective sensing [8c] UiO-66 TPP-SH Post-synthesis PDT [111] UiO-AM TAPP Post-synthesis PDT [114] ICR-2 TPPPi(R), R = methyl, isopropyl, phenyl
Post-synthesis PDT [27] MIL-101(Al)-NH2 Hemin Post-synthesis Detection of H2O2, glucose [93] Cu-MOF-74 Hemin Post-synthesis 2,4,6-trichlorophenol sensing [115] Table 2 . Typical examples of porphyrinic MOFs for biomedical applications.
MOFs
Metal centers
Porphyrins
Other components Biomedical applications Refs.
PCN-221
Zr 4+ TCPP MTX Chemotherapy [64] PCN-222 Zr 4+ TCPP ss-DNA-tagged antibody (Ab-DNA) PSA sensing [88] PCN-222 Zr 4+ TCPP Label-free phosphoprotein (α-casein) sensing [91] PCN-222 Zr 4+ TCPP Reversible colorimetric and fluorescent low pH response [116] PCN MOF-525 Zr 4+ TCPP Nitrite detection [118] MOF-525 Zr 4+ TCPP Luminescent sensing of Cu 2+ [97] MOF-525(Zn) Zr 4+ TCPP(Zn) PKA activity assay [92] NPMOF Zr 4+ TCPP DOX Chemotherapy, PDT; fluorescence imaging [37a] 10.1002/anie.201909880
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This article is protected by copyright. All rights reserved. [90] TBP-NMOF Zr 4+ TBP/TBP(Cu) PDT, immunotherapy [70] Zr-FeP Zr 4+ TBP(Fe) Heat shock protein 70 siRNA PDT, low-temperature PTT; PTI, PAI, CT [66] DBP-UiO Hf 4+ DBP PDT [42] R-UiO Hf 4+ DBP(Pt) QPDC-NH2 ligand, RBITC Intracellular O2 sensing [36b] DBC-UiO Hf 4+ DBC PDT [47] Hf-TCPP Hf 4+ TCPP C18PMH-PEG PDT, RT [44] TCPC-UiO Hf 4+ TCPC BDC ligand PTT, PDT; CT, PTI, PAI [36f] TBC-Hf/TBP-Hf Hf 4+ TBC/TBP IDOi (INCB24360) PDT, immunotherapy [69a] MOF-2 Al 3+ TCPP(Cu) PDT [58] PAC Al 3+ TCPP(Cu) Detection of intracellular H2S [94] Gd-TCPP Gd 3+ TCPP PDT; MRI Fe-TBP Fe 3+ TBP PDT, immunotherapy [56a] Cu-TCPP Cu 2+ TCPP PTT, PDT; MRI, PTI [67] Cu-TCPP Cu 2+ TCPP Selective generation of 1 O2 [60] Cu-TCPP Cu 2+ TCPP Fluorometric determination of the target DNAs [87] Cu-TCPP(Fe) Cu 2+ TCPP(Fe) Cisplatin Chemotherapy, highly increased generation of ROS Pd-MOF Pd 2+ TPyP Hydrogen gas Hydrogenothermal therapy; PAI [74] [98] RB-PCN PCN-224 Fe3O4, RBITC Broad-range pH sensor for fluorescence imaging [102] AuNR@MOFs@CPT Zr-TCPP Au nanorods, CPT PDT, PTT, chemotherapy; fluorescence imaging [38a] PDA@MOF Zr-TCPP PDA nanoparticles PTT, PDT
REVIEW
[38g]
Fe3O4@C@PMOF
Zr-TCPP Fe3O4@C nanospheres PTT, PDT; MRI, fluorescence imaging [79] NMOF-SNO Zr-TCPP(Mn) S-nitrosothiol Gas therapy, PTT; MRI [81] MOF-525-PEDOT NTs MOF-525 Poly(3,4-ethylenedioxythiophene) nanotubes Detection of DA [95] 10.1002/anie.201909880
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